Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: Implications for new control strategies.
The number of new cases of leprosy reported worldwide has remained essentially unchanged for the last decade despite continued global use of free multidrug therapy (MDT) provided to any diagnosed leprosy patient. In order to more effectively interrupt the chain of transmission, new strategies will b...
Guardado en:
Autores principales: | Moises Batista da Silva, Wei Li, Raquel Carvalho Bouth, Angélica Rita Gobbo, Ana Caroline Cunha Messias, Tania Mara Pires Moraes, Erika Vanessa Oliveira Jorge, Josafá Gonçalves Barreto, Fred Bernardes Filho, Guilherme Augusto Barros Conde, Marco Andrey Cipriani Frade, Claudio Guedes Salgado, John Stewart Spencer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d197ce8dad04cdda5bbe4f1ac4a366b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
RLEP LAMP for the laboratory confirmation of leprosy: towards a point-of-care test
por: Malkin Saar, et al.
Publicado: (2021) -
Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study.
por: Nádia C Düppre, et al.
Publicado: (2012) -
Some New Characterizations for PGL(2, q)
por: Khosravi,B, et al.
Publicado: (2011) -
Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae
por: Andrej Benjak, et al.
Publicado: (2018) -
Innovative tracking, active search and follow-up strategies for new leprosy cases in the female prison population.
por: Claudia Maria Lincoln Silva, et al.
Publicado: (2021)